Anti–Vascular Endothelial Growth Factor with Gas for Submacular Hemorrhage
- 1 February 2016
- journal article
- research article
- Published by Wiley in Optometry and Vision Science
- Vol. 93 (2) , 173-180
Abstract
Purpose: To investigate the treatment outcome of pneumatic displacement and intravitreal anti–vascular endothelial growth factor (VEGF) for submacular hemorrhage (SMH) from exudative age‐related macular degeneration (AMD). Methods: Best‐corrected visual acuity (BCVA) and central foveal thickness (CFT) were measured at baseline and at 1, 3, and 6 months after initial treatment in 72 eyes of 72 patients treated with a combination of pneumatic displacement and anti‐VEGF injection for SMH from exudative AMD. Results: Best‐corrected visual acuity and CFT showed significant improvement from baseline during the 6‐month follow‐up period (logarithm of the minimum angle of resolution BCVA from 1.80 to 1.00, CFT from 886 to 383 μm, p < 0.001, respectively). The decrease in subretinal hemorrhage was greater than that in subretinal pigment epithelial hemorrhage at 1 month after initial treatment (p < 0.001). In eyes with symptoms for less than 30 days, higher reflectivity of hemorrhage on optical coherence tomography and higher CFT were associated with lower BCVA after 6 months of treatment (reflectivity B = 0.335, p = 0.007; CFT B = 0.001, p = 0.003). Conclusions: The combination of pneumatic displacement and intravitreal anti‐VEGF is a useful treatment option for SMH secondary to AMD. Higher baseline CFT and higher reflectivity of hemorrhage were associated with lower BCVA 6 months after initial treatment.Keywords
Funding Information
- National Research Foundation of Korea
- Ministry of Higher Education and Scientific Research (2013R1A1A2007865)
This publication has 38 references indexed in Scilit:
- Submacular haemorrhages associated with neovascular age-related macular degenerationBritish Journal of Ophthalmology, 2010
- Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: Ophthalmic findingsSST report no. 13Ophthalmology, 2004
- Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacementOphthalmology, 1999
- Natural History of Macular Subretinal Hemorrhage in Age-Related Macular DegenerationOphthalmologica, 1999
- Pneumatic Displacement of Subretinal Hemorrhage Without Tissue Plasminogen ActivatorArchives of Ophthalmology (1950), 1998
- Variations in the Clinical Course of Submacular HemorrhageAmerican Journal of Ophthalmology, 1996
- NATURAL HISTORY OF SUBFOVEAL SUBRETINAL HEMORRHAGE IN AGERELATED MACULAR DEGENERATIONRetina, 1996
- Fibrin Directs Early Retinal Damage After Experimental Subretinal HemorrhageArchives of Ophthalmology (1950), 1991
- Surgical Removal of Massive Subretinal Hemorrhage Associated with age-related Macular DegenerationOphthalmology, 1991
- Experimental Subretinal Hemorrhage in RabbitsAmerican Journal of Ophthalmology, 1982